Abstract
Cardiovascular disease (CVD) is one of many common diseases for which there appear to be multiple genetic and environmental risk factors that interact with one another during the disease process. Among some families, causative mutations in certain genes have been ident ified, such as for familial hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome (reviewed by Maron et al. 1998); however, the association of these same genes with common forms of CVD is not fully understood. Extensive epidemiological studies have identified risk factors for disease in the general population, including age and gender, high serum cholesterol levels and hypertension, cigarette smoking, and physical inactivity (reviewed by Pasternak et al. 1996). Familial clustering (ten Kate et al. 1982) and twin studies (Marenberg et al. 1994) indicate that family history is an independent risk factor, particularly for individuals before the age of 55, and that this is not entirely explained by familial aggregation of hyperlipidemia, diabetes mellitus, obesity, and hypertension. Many premature CVD cases remain unexpl ained (Hoeg 1997), and unknown risk factors may be primarily genetic. These genetic risk factors may include the cumulative effects of common allelic variants; although individual variants may contribute only a modest increase in risk, combinations of particular alleles may confer significantly greater risk for disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramson RD (1995) Thermostable DNApolymerases. In: Innis MA, Gelfand DH, Sninsky JJ (eds) PCR strategies. Academic Press, San Diego, pp 39–57
Birch DE, Kolmodin L, Wong J, Zangenberg GA, Zoccoli MA (1996) Simplified hot start PCR. Nature 381:445–446
Chamberlain JS, Chamberlain JR (1994) Optimization of multiplex PCRs. In: Mullis KB, Ferre F, Gibbs RA (eds) The polymerase chain reaction. Birkhäuser, Boston, pp 38–46
Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT (1988) Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16:11141–11156
Cheng S, Pallaud C, Grow MA, Scharf SJ, Erlich HA, Klitz W, Pullinger CR, Malloy MJ, Kane JP, Siest G, Visvikis S (1998) A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med 36:561–566
Chou Q, Russell M, Birch DE, Raymond J, Bloch W (1992) Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res 20: 1717–1723
Goyette P, Frosst P, Rosenblatt DS, Rozen R (1995) Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 56:1052–1059
Henegariu O, Heerema NA, Dlouhy SR, Vance GH, Vogt PH (1997) Multiplex PCR: critical parameters and step-by-step protocol. Biotechniques 23:504–511
Higuchi R, Krummel B, Saiki RK (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 16:7351–7367
Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548
Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59
Hoeg JM (1997) Evaluating coronary heart disease risk. JAMA 277:1387–1390
Houlston RS, Snowden C, Green F, Alberti KGMM, Humphries SE (1989) Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apo E and apo Cll. Hum Genet 83:364–368
Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE (1993) Molecular basis of cystathionine β-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet 2:1857–1860
Kebelmann-Betzing C, Seeger K, Dragon S, Schmitt G, Möricke A, Schild TA, Henze G, Beyermann B (1998) Advantages of a new Taq DNA polymerase in multiplex PCR and time-release PCR. Biotechniques 24:154–158
Kellogg DE, Rybalkin I, Chen S, Mukhamedova N, Vlasik T, Siebert PD, Chenchik A (1994) TaqStart antibody: “hot start” PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques 16:1134–1137
Landre PA, Gelfand DH, Watson RM (1995) The use of cosolvents to enhance amplification by the polymerase chain reaction. In: Innis MA, Gelfand DH, Sninsky JJ (eds) PCR strategies. Academic Press, San Diego, pp 3–16
Lawyer FC, Stoffel S, Saiki RK, Myambo K, Drummond R, Gelfand DH (1989) Isolation, characterization, and expression in Escherichia coli of the DNA polymerase gene from Thermus aquaticus. J Biol Chem 264:6427–6437
Lawyer FC, Stoffel S, Saiki RK, Chang S-Y, Landre PA, Abramson RD, Gelfand DH (1993) Highlevel expression, purification, and enzymatic characterization of full-length Thermus aquaticus DNA polymerase and a truncated form deficient in 5′ to 3′ exonuclease activity. PCR Methods Appl 2:275–287
Li H, Cui X, Arnheim N (1990) Direct electrophoretic detection of the allelic state of single DNA molecules in human sperm by using the polymerase chain reaction. Proc Natl Acad Sci USA 87:4580–4584
Longo MC, Berninger MS, Hartley JL (1990) Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93:125–128
Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041–1046
Maron BJ, Moller JH, Seidman CE, Vincent GM, Dietz HC, Moss AJ, Towbin JA, Sondheimer HM, Pyeritz RE, McGee G, Epstein AE (1998) Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. Circulation 98:1460–1471
McConlogue L, Brow MAD, Innis MA (1988) Structure-independent DNA amplification by PCR using 7-deaza-2′-deoxyguanosine. Nucleic Acids Res 16:9869
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNAfrom human nucleated cells. Nucleic Acids Res 16:1215
Mullis KB, Faloona FA (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155:335–350
Pasternak RC, Grundy SM, Levy D, Thompson PD (1996) 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 3. Spectrum of risk factors for coronary heart disease. J Am Coli Cardiol 27:978–990
Pomp D, Medrano JF (1991) Organic solvents as facilitators of polymerase chain reaction. Biotechniques 10:58–59
Rees WA, Yager TD, Korte J, von Hippel PH (1993) Betaine can eliminate the base pair composition dependence of DNA melting. Biochemistry 32:137–144
Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW (1993) Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 2:159–163
Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912–917
Rychlik W, Spencer WJ, Rhoads RE (1990) Optimization of the annealing temperature for DNA amplification in vitro. Nucleic Acids Res 18:6409–6412
Saiki RK, Erlich HA (1998) Detect ion of mutations by hybridization with sequence-specific oligonucleotide probes. In: Cotton RGH, Edkins E, Forrest S (eds) Mutation detection: a practical approach. Oxford University Press, Oxford, pp 113–129
Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA (1986) Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324:163–166
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Saiki RK, Walsh PS, Levenson CH, Erlich HA (1989) Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci USA 86:6230–6234
Santoro MM, Liu Y, Khan SMA, Hou L-X, Bolen DW (1992) Increased thermal stability of proteins in the presence of naturally occurring osmolytes. Biochemistry 31:5278–5283
Schafer AJ, Hawkings JR (1998) DNA variation and the future of human genetics. Nat Biotechnol 16:33–39
ten Kate LP, Boman H, Daiger SP, Motulsky AG (1982) Familial aggregation of coronary heart disease and its relation to known genetic risk factors. Am J Cardiol 50:945–953
Thein SL, Wallace RB (1986) The use of synthetic oligonucleotides as specific hybrid ization probes in the diagnosis of genet ic disorders. In: Davies KE (ed) Human genetic diseases. IRL Press, Oxford, pp33–50
Tung CH, Rudolph MI, Stein S (1991) Preparation of oligonucleotide-peptide conjugates. Bioconjug Chem 2:464–465
Turner SL, Jenkins FJ (1995) Use of deoxyinosine in PCR to improve amplification of GC-rich DNA. Biotechniques 19:48–52
Wallace RB, Shaffer J, Murphy RF, Bonner J, Hirose T, Itakura K (1979) Hybridization of synthetic oligodeoxyribonucleotides to Φχ174 DNA: the effect of single base pair mismatch. Nucleic Acids Res 6:3543–3557
Walsh PS, Erlich HA, Higuchi R (1992) Preferential PCR amplification of alleles: mechanisms and solutions. PCR Methods Appll:241–250
Weiss J, Zucht H-D, Forssmann W-G (1994) Amplification of gene fragments with very high G/C content: c7dGTP and the problem of visualizing the amplification products. PCR Methods Appl 4:124–125
Weissensteiner T, Lanchbury JS (1996) Strategy for controlling preferential amplification and avoiding false negatives in PCR typing. Biotechniques 21:1102–1108
Zangenberg G, Saiki RK, Reynolds R (1999) Multiplex PCR: optimization guidelines. In: Innis MA, Gelfand DH, Sninsky JJ (eds) PCR applications: protocols for functional genomics. Academic Press, San Diego, pp 73–94
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cheng, S. (2003). Multiplex Polymerase Chain Reaction and Immobilized Probes: Application to Cardiovascular Disease. In: Day, I.N.M. (eds) Molecular Genetic Epidemiology — A Laboratory Perspective. Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56207-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-56207-5_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41387-5
Online ISBN: 978-3-642-56207-5
eBook Packages: Springer Book Archive